Second, although increased biosynthesis of prostaglandins is known to occur in endometrial cancers we believe our study provides the first evidence that down-regulation in expression of ERα, and the consequent reduction in expression of PR, may be one of the downstream consequences of F prostaglandin-dependent signalling. The gene discussed is PGR; the disease is endometrial cancer.